GetPortalImpactFactorByIdResp(projectId=1, id=b1255470, cover=https://img.medsci.cn/images/journal/cover/2021/Fym_202109271316146550.jpg, fullname=ONCOLOGY RESEARCH, abbr=ONCOL RES, pyear=1992, frequence=Bimonthly, articleNumbers=949, citedSelf2015=2.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.14月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0965-0407, greenSci=https://www.greensci.net/search?kw=0965-0407, scijournal=https://www.scijournal.org/impact-factor-of-ONCOL-RES.shtml, medsciHotlightString=null, medsciHotlightRealtime=11.32, medsciHotlight=9.554, medsciHotlight5year=14.0926, citescore=10.7, hIndex=57, impactFactor=3.1, orgnization=Cognizant Communication Corporation, orgnizationUrl=https://www.cognizantcommunication.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 2 区, website=https://www.cognizantcommunication.com/journal-titles/oncology-research, websiteHits=25412, guideForAuthor=https://www.cognizantcommunication.com/journal-titles/oncology-research, guideForAuthorHits=460, submitWebsite=https://www.cognizantcommunication.com/journal-titles/oncology-research, submitWebsiteHits=4936, content=<p>Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of preclinical, translational, and clinical cancer therapeutics.Specific areas of interest include preclinical and translational research in development of novel small molecules and targeted therapies; mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics;pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. As part of the preclinical cancer therapeutics focus, the journal also prioritizes preclinical studies that are focused on drug design, chemical biology, and drug screening. While the journal’s primary focus is on small molecules and protein drugs, other molecular entities may be considered. In addition, submissions that investigate the potential role of herbal/botanical medicines in preclinical and clinical cancer therapy are welcomed; however, it will be important to document that these medicines are of high quality, with confirmation of batch to batch consistency. In addition to original peer-reviewed articles, the journal also welcomes timely reviews and/or commentaries on topics that focus on preclinical, translational, and/or clinical cancer therapeutics.</p>, totalCites=2942, brief=ONCOL RES杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的偏低级别杂志, articleType=论著，综述各类型文章都接收, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=ONCOL RES杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=b1255470'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=29), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=29), ImpactFactorTagDto(id=809, tagName=白血病, createdHits=1), ImpactFactorTagDto(id=4125, tagName=胃肠肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.95), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.92), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.73), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=13.349), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=9.831), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=9.592), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=12.878), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=11.32)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=68/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=63/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q4)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0965-0407[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ONCOLOGY RESEARCH[ta], article_number=12, article_number_cn=6, earlyWarning=吉大一院预警；中南大学湘雅二医院--中；上海瑞金医院--中；, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)